370 related articles for article (PubMed ID: 21471977)
1. Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats.
Nakamura T; Fukuda M; Kataoka K; Nako H; Tokutomi Y; Dong YF; Yamamoto E; Yasuda O; Ogawa H; Kim-Mitsuyama S
Hypertens Res; 2011 Jul; 34(7):817-24. PubMed ID: 21471977
[TBL] [Abstract][Full Text] [Related]
2. Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats.
Du J; Fan YY; Hitomi H; Kiyomoto H; Kimura S; Kong CZ; Noma T; Kohno M; Nishiyama A; Nakano D
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F802-8. PubMed ID: 19535572
[TBL] [Abstract][Full Text] [Related]
3. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
Yamamoto E; Kataoka K; Shintaku H; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2569-75. PubMed ID: 17932313
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of combination of valsartan and amlodipine on salt-induced brain injury in hypertensive rats.
Dong YF; Kataoka K; Tokutomi Y; Nako H; Nakamura T; Toyama K; Sueta D; Koibuchi N; Yamamoto E; Ogawa H; Kim-Mitsuyama S
J Pharmacol Exp Ther; 2011 Nov; 339(2):358-66. PubMed ID: 21807884
[TBL] [Abstract][Full Text] [Related]
5. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
[TBL] [Abstract][Full Text] [Related]
6. Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
Endemann DH; Touyz RM; Iglarz M; Savoia C; Schiffrin EL
Hypertension; 2004 Jun; 43(6):1252-7. PubMed ID: 15117913
[TBL] [Abstract][Full Text] [Related]
7. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.
Bayorh MA; Mann G; Walton M; Eatman D
Clin Exp Hypertens; 2006 Feb; 28(2):121-32. PubMed ID: 16546838
[TBL] [Abstract][Full Text] [Related]
8. Effects of eplerenone, a selective mineralocorticoid receptor antagonist, on clinical and experimental salt-sensitive hypertension.
Takeda Y
Hypertens Res; 2009 May; 32(5):321-4. PubMed ID: 19300447
[TBL] [Abstract][Full Text] [Related]
9. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts.
Kobayashi N; Yoshida K; Nakano S; Ohno T; Honda T; Tsubokou Y; Matsuoka H
Hypertension; 2006 Apr; 47(4):671-9. PubMed ID: 16505212
[TBL] [Abstract][Full Text] [Related]
11. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH
Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164
[TBL] [Abstract][Full Text] [Related]
12. Additive beneficial effects of amlodipine and atorvastatin in reversing advanced cardiac hypertrophy in elderly spontaneously hypertensive rats.
Lu JC; Cui W; Zhang HL; Liu F; Han M; Liu DM; Yin HN; Zhang K; Du J
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1110-9. PubMed ID: 19413592
[TBL] [Abstract][Full Text] [Related]
13. Role of mineralocorticoid receptor on atrial structural remodeling and inducibility of atrial fibrillation in hypertensive rats.
Kimura S; Ito M; Tomita M; Hoyano M; Obata H; Ding L; Chinushi M; Hanawa H; Kodama M; Aizawa Y
Hypertens Res; 2011 May; 34(5):584-91. PubMed ID: 21248754
[TBL] [Abstract][Full Text] [Related]
14. Effect of eplerenone on endothelial progenitor cells and oxidative stress in ischemic hindlimb.
Kobayashi N; Fukushima H; Takeshima H; Koguchi W; Mamada Y; Hirata H; Machida Y; Suzuki N; Yokotsuka F; Tabei K; Kobayashi E; Fukuda N; Ishimitsu T
Am J Hypertens; 2010 Sep; 23(9):1007-13. PubMed ID: 20431528
[TBL] [Abstract][Full Text] [Related]
15. Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects.
Yamamoto E; Yamashita T; Tanaka T; Kataoka K; Tokutomi Y; Lai ZF; Dong YF; Matsuba S; Ogawa H; Kim-Mitsuyama S
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):556-63. PubMed ID: 17170375
[TBL] [Abstract][Full Text] [Related]
16. CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats.
Arai K; Tsuruoka H; Homma T
Eur J Pharmacol; 2015 Dec; 769():266-73. PubMed ID: 26607463
[TBL] [Abstract][Full Text] [Related]
17. Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker.
Nagase M; Shibata S; Yoshida S; Nagase T; Gotoda T; Fujita T
Hypertension; 2006 Jun; 47(6):1084-93. PubMed ID: 16636193
[TBL] [Abstract][Full Text] [Related]
18. Symptoms and the distress they cause: comparison of an aldosterone antagonist and a calcium channel blocking agent in patients with systolic hypertension.
Hollenberg NK; Williams GH; Anderson R; Akhras KS; Bittman RM; Krause SL
Arch Intern Med; 2003 Jul; 163(13):1543-8. PubMed ID: 12860576
[TBL] [Abstract][Full Text] [Related]
19. Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation.
Zhou MS; Schulman IH; Raij L
J Hypertens; 2010 Mar; 28(3):527-35. PubMed ID: 19898250
[TBL] [Abstract][Full Text] [Related]
20. Eplerenone offsets cardiac and aortic adverse remodeling in spontaneously hypertensive rats.
Burla AK; Neves MF; Oigman W; Mandarim-de-Lacerda CA
Int J Cardiol; 2007 Jan; 114(1):64-70. PubMed ID: 16650491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
